Back to search

Article

HIV treatment simplification : outcomes of switching HIV-1 patients to protease-inhibitor maintenance monotherapy

2020-01-01

Abstract excerpt

The work in this thesis characterised the virological outcomes of HIV-1 patients on second-line ART switching to boosted-darunavir maintenance monotherapy in sub-Saharan Africa and explored their determinants, with the aim of providing evidence to inform practice and policy. Firstly, I took advantage of samples and data collected within a trial of maintenance monotherapy that was conducted in Yaoundé, Cameroon, b...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
304eb049-a1cf-519f-9229-f6ce853e939a
DOI
10.17638/03110378
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
HIV treatment simplification : outcomes of switching HIV-1 patients to protease-inhibitor maintenance monotherapyDOI 10.17638/03110378
A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance.Semantic proximity
Trends in Genotypic HIV-1 Antiretroviral Resistance between 2006 and 2012 in South African Patients Receiving First- and Second-Line Antiretroviral Treatment Regimens.Semantic proximity
Viral suppression following switch to second-line antiretroviral therapy: associations with nucleoside reverse transcriptase inhibitor resistance and subtherapeutic drug concentrations prior to switch.Semantic proximity
Lack of impact of protease inhibitor resistance-associated mutations on the outcome of HIV-1-infected patients switching to darunavir-based dual therapy.Semantic proximity
Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART StrategiesSemantic proximity
Viremia, resuppression, and time to resistance in human immunodeficiency virus (HIV) subtype C during first-line antiretroviral therapy in South Africa.Semantic proximity
Low levels of HIV-1 drug resistance mutations in patients who achieved viral re-suppression without regimen switch: a retrospective study.Semantic proximity
HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan Africa.Semantic proximity
Rate of Initial Anti-retroviral Treatment Modification and Its Predictors Among Adult Hiv/aids Patients at Pawe General Hospital, Benishangul Gumuz Region, Northwest EthiopiaSemantic proximity
Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa.Semantic proximity
Clinical outcomes with second-line dolutegravir in people with virological failure on first-line non-nucleoside reverse transcriptase inhibitor-based regimens in South Africa: a retrospective cohort studySemantic proximity
Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA).Semantic proximity
Select a neighboring publication to make it the new centre.